You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 74 No. 3, September 1956 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Serum Anticoagulant Factor in Systemic Lupus Erythematosus

SHELDON SWIFT, M.B., Ch.B. (Liverpool), M.R.C.S. (England), L.R.C.P. (London)

AMA Arch Derm. 1956;74(3):296-299.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The concept of lupus erythematosus as an immunologic disease is gaining popularity. Certain cases of lupus erythematosus present as hemolytic anemia, and the Coombs test may be positive in these, and indeed may reveal the presence of circulating antibodies in other cases of lupus erythematosus in which hemolysis is not apparent. A false-positive serology is also an indication of an immunologic reaction. It is of great interest, therefore, to find lupus erythematosus associated with any other immunologic phenomenon. Recently the attention of hematologists has been drawn to a small number of patients with a hemorrhagic disturbance due to a circulating anticoagulant. There is evidence that in some of these cases the anticoagulant is formed by an immunologic process. Craddock and Lawrence have reported the development of an anticoagulant in hemophilia following repeated therapy with blood, plasma, or antihemophilic globulin.1 Several anticoagulant factors have been . . . [Full Text PDF of this Article]


Author Affiliations

Portland, Ore.

From the Division of Dermatology, the University of Oregon Medical School.


Footnotes

Submitted for publication Oct. 12, 1955.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1956 American Medical Association. All Rights Reserved.